2024 Q2 Form 10-Q Financial Statement

#000147793224002277 Filed on April 22, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1 2023 Q2
Revenue $247.2K $2.010K
YoY Change 3060.19%
Cost Of Revenue $223.8K -$170.00
YoY Change 18703.19%
Gross Profit $23.46K $2.180K
YoY Change 253.69%
Gross Profit Margin 9.49% 108.46%
Selling, General & Admin $267.4K $1.357M
YoY Change 7.39%
% of Gross Profit 1139.41% 62250.0%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $0.00 $400.00
YoY Change -100.0%
% of Gross Profit 0.0% 18.35%
Operating Expenses $394.9K $1.323M
YoY Change 0.76% 548.75%
Operating Profit -$371.4K -$1.321M
YoY Change -3.6% 547.69%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net -$99.87K -$20.82K
YoY Change -841.11%
Pretax Income -$471.3K -$1.342M
YoY Change 26.76% 557.89%
Income Tax
% Of Pretax Income
Net Earnings -$471.3K -$1.342M
YoY Change 26.76% 557.89%
Net Earnings / Revenue -190.63% -66758.21%
Basic Earnings Per Share
Diluted Earnings Per Share -$0.01 -$0.02
COMMON SHARES
Basic Shares Outstanding 78.66M shares 70.04M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2024 Q2 2024 Q1 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $212.1K $206.8K
YoY Change 107.55% -56.67%
Cash & Equivalents $2.675M $212.1K $206.8K
Short-Term Investments
Other Short-Term Assets $94.48K $59.77K
YoY Change -66.72%
Inventory $316.7K $223.6K $80.75K
Prepaid Expenses $1.000K $94.48K $59.77K
Receivables $24.78K
Other Receivables $26.55K
Total Short-Term Assets $2.797M $357.9K $312.2K
YoY Change 795.88% 166.82% -53.25%
LONG-TERM ASSETS
Property, Plant & Equipment $6.918K $7.503K $9.116K
YoY Change -24.11% 36.24% 180.15%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $2.564M $0.00 $1.514M
YoY Change 69.31% -100.0%
Other Assets $231.2K $88.27K
YoY Change 155.8% 14370.49%
Total Long-Term Assets $1.174M $819.2K $2.203M
YoY Change -46.71% -55.44% 56867.73%
TOTAL ASSETS
Total Short-Term Assets $2.797M $357.9K $312.2K
Total Long-Term Assets $1.174M $819.2K $2.203M
Total Assets $3.971M $1.177M $2.515M
YoY Change 57.87% -40.32% 274.5%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $127.2K $134.1K $69.73K
YoY Change 82.44% 136.68% 126.74%
Accrued Expenses $35.30K $24.75K
YoY Change 1020.63% 730.54%
Deferred Revenue
YoY Change
Short-Term Debt $36.50K $151.6K $100.0K
YoY Change -63.5% 52.25%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $839.8K $367.3K $194.5K
YoY Change 331.8% 110.78% 476.58%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $418.9K $37.71K $55.42K
YoY Change 655.86%
Total Long-Term Liabilities $418.9K $37.71K $55.42K
YoY Change 655.86%
TOTAL LIABILITIES
Total Short-Term Liabilities $839.8K $367.3K $194.5K
Total Long-Term Liabilities $418.9K $37.71K $55.42K
Total Liabilities $1.142M $405.1K $249.9K
YoY Change 357.12% 132.42% 640.87%
SHAREHOLDERS EQUITY
Retained Earnings -$4.937M -$4.356M -$2.192M
YoY Change 125.23% 412.33% 973.36%
Common Stock $82.18K $78.66K $72.58K
YoY Change 13.22% 12.31% 6.23%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $2.828M $772.1K $2.265M
YoY Change
Total Liabilities & Shareholders Equity $3.971M $1.177M $2.515M
YoY Change 57.87% -40.32% 274.5%

Cashflow Statement

Concept 2024 Q2 2024 Q1 2023 Q2
OPERATING ACTIVITIES
Net Income -$471.3K -$1.342M
YoY Change 26.76% 557.89%
Depreciation, Depletion And Amortization $0.00 $400.00
YoY Change -100.0%
Cash From Operating Activities -$454.0K -$612.2K
YoY Change -6.23% 69.35%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $69.83K
YoY Change -100.0% -2248.62%
Acquisitions
YoY Change
Other Investing Activities -$25.00K -$397.5K
YoY Change
Cash From Investing Activities -$25.00K -$467.4K
YoY Change -75.96% 14280.31%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 137.8K 1.176M
YoY Change -77.02% 37.59%
NET CHANGE
Cash From Operating Activities -454.0K -612.2K
Cash From Investing Activities -25.00K -467.4K
Cash From Financing Activities 137.8K 1.176M
Net Change In Cash -341.2K 96.82K
YoY Change -3079.83% -80.25%
FREE CASH FLOW
Cash From Operating Activities -$454.0K -$612.2K
Capital Expenditures $0.00 $69.83K
Free Cash Flow -$454.0K -$682.0K
YoY Change -22.81% 90.38%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 us-gaap Investments
Investments
0 usd
CY2024Q1 us-gaap Security Deposit
SecurityDeposit
7537 usd
CY2024Q1 us-gaap Assets
Assets
1177151 usd
CY2024Q1 us-gaap Operating Expenses
OperatingExpenses
394863 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
391898 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-385265 usd
CY2024Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-99872 usd
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
13476 usd
CY2024Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
11779 usd
CY2023Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
10061 usd
CY2024Q1 us-gaap Liabilities Current
LiabilitiesCurrent
367343 usd
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
194481 usd
CY2024Q1 us-gaap Liabilities
Liabilities
405055 usd
CY2023Q2 us-gaap Liabilities
Liabilities
249896 usd
CY2024Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 usd
CY2023Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 usd
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
78664 usd
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
72579 usd
CY2024Q1 karx Shares To Be Issued
SharesToBeIssued
74998 usd
CY2023Q2 karx Shares To Be Issued
SharesToBeIssued
1750000 usd
CY2024Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
5009285 usd
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
2638532 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-4356124 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2192106 usd
CY2024Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-34727 usd
CY2023Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-3786 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
772096 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
2265219 usd
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1177151 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2515115 usd
CY2024Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
37710 usd
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
55415 usd
dei Entity Central Index Key
EntityCentralIndexKey
0001729637
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--05-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Transition Report
DocumentTransitionReport
false
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
78664969 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
72579000 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
0
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Other Share Increase Decrease In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsOtherShareIncreaseDecreaseInPeriodWeightedAverageExercisePrice
0
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-02-29
dei Entity File Number
EntityFileNumber
000-56288
dei Entity Registrant Name
EntityRegistrantName
KARBON-X CORP.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
82-2882342
dei Entity Address Address Line1
EntityAddressAddressLine1
910 7th Ave SW
dei Entity Address City Or Town
EntityAddressCityOrTown
Calgary
dei Entity Address Country
EntityAddressCountry
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
T2P 3N8
dei City Area Code
CityAreaCode
778
dei Local Phone Number
LocalPhoneNumber
256-5730
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
78664969 shares
CY2023Q2 us-gaap Investments
Investments
1514483 usd
CY2023Q2 us-gaap Security Deposit
SecurityDeposit
7515 usd
CY2023Q2 us-gaap Assets
Assets
2515115 usd
CY2024Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
134096 usd
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
69732 usd
CY2024Q1 us-gaap Line Of Credit
LineOfCredit
8819 usd
CY2023Q2 us-gaap Line Of Credit
LineOfCredit
0 usd
CY2024Q1 karx Due From Related Party Current
DueFromRelatedPartyCurrent
37486 usd
CY2023Q2 karx Due From Related Party Current
DueFromRelatedPartyCurrent
0 usd
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
78664969 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
72579000 shares
CY2024Q1 us-gaap Revenues
Revenues
247222 usd
CY2023Q1 us-gaap Revenues
Revenues
7823 usd
CY2024Q1 us-gaap Cost Of Revenue
CostOfRevenue
223758 usd
CY2023Q1 us-gaap Cost Of Revenue
CostOfRevenue
1190 usd
CY2024Q1 us-gaap Gross Profit
GrossProfit
23464 usd
CY2023Q1 us-gaap Gross Profit
GrossProfit
6633 usd
CY2024Q1 us-gaap Marketing Expense
MarketingExpense
66629 usd
CY2023Q1 us-gaap Marketing Expense
MarketingExpense
17928 usd
CY2024Q1 us-gaap Salaries And Wages
SalariesAndWages
149533 usd
CY2023Q1 us-gaap Salaries And Wages
SalariesAndWages
0 usd
CY2024Q1 us-gaap Professional Fees
ProfessionalFees
51188 usd
CY2023Q1 us-gaap Professional Fees
ProfessionalFees
231020 usd
CY2024Q1 us-gaap Other Expenses
OtherExpenses
127513 usd
CY2023Q1 us-gaap Other Expenses
OtherExpenses
142950 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-371399 usd
CY2024Q1 us-gaap Impairment Of Investments
ImpairmentOfInvestments
0 usd
CY2023Q1 us-gaap Impairment Of Investments
ImpairmentOfInvestments
0 usd
CY2024Q1 us-gaap Federal Income Tax Expense Benefit Continuing Operations
FederalIncomeTaxExpenseBenefitContinuingOperations
0 usd
CY2023Q1 us-gaap Federal Income Tax Expense Benefit Continuing Operations
FederalIncomeTaxExpenseBenefitContinuingOperations
0 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-471271 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-371789 usd
CY2024Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-20561 usd
CY2023Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
33371 usd
CY2024Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-491832 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-338418 usd
CY2024Q1 karx Weighted Average Basic And Diluted Shares Outstanding
WeightedAverageBasicAndDilutedSharesOutstanding
77617191 shares
CY2023Q1 karx Weighted Average Basic And Diluted Shares Outstanding
WeightedAverageBasicAndDilutedSharesOutstanding
69323708 shares
CY2024Q1 karx Earnings Per Share Basic And Fully Diluted
EarningsPerShareBasicAndFullyDiluted
-0.01
CY2023Q1 karx Earnings Per Share Basic And Fully Diluted
EarningsPerShareBasicAndFullyDiluted
-0.01
us-gaap Revenues
Revenues
287062 usd
us-gaap Revenues
Revenues
7823 usd
us-gaap Cost Of Revenue
CostOfRevenue
237959 usd
us-gaap Cost Of Revenue
CostOfRevenue
1190 usd
us-gaap Gross Profit
GrossProfit
49103 usd
us-gaap Gross Profit
GrossProfit
6633 usd
us-gaap Marketing Expense
MarketingExpense
95468 usd
us-gaap Marketing Expense
MarketingExpense
36912 usd
us-gaap Salaries And Wages
SalariesAndWages
464274 usd
us-gaap Salaries And Wages
SalariesAndWages
0 usd
us-gaap Professional Fees
ProfessionalFees
201650 usd
us-gaap Professional Fees
ProfessionalFees
324347 usd
us-gaap Other Expenses
OtherExpenses
262302 usd
us-gaap Other Expenses
OtherExpenses
305377 usd
us-gaap Operating Expenses
OperatingExpenses
1023694 usd
us-gaap Operating Expenses
OperatingExpenses
666636 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-974591 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-660003 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1188775 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
13969 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2163366 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-646034 usd
us-gaap Federal Income Tax Expense Benefit Continuing Operations
FederalIncomeTaxExpenseBenefitContinuingOperations
0 usd
us-gaap Federal Income Tax Expense Benefit Continuing Operations
FederalIncomeTaxExpenseBenefitContinuingOperations
0 usd
us-gaap Net Income Loss
NetIncomeLoss
-2163366 usd
us-gaap Net Income Loss
NetIncomeLoss
-646034 usd
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-30941 usd
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
1398 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2194308 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-644636 usd
karx Weighted Average Basic And Diluted Shares Outstanding
WeightedAverageBasicAndDilutedSharesOutstanding
77017953 shares
karx Weighted Average Basic And Diluted Shares Outstanding
WeightedAverageBasicAndDilutedSharesOutstanding
69077537 shares
karx Earnings Per Share Basic And Fully Diluted
EarningsPerShareBasicAndFullyDiluted
-0.03
karx Earnings Per Share Basic And Fully Diluted
EarningsPerShareBasicAndFullyDiluted
-0.01
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
1189582 usd
CY2024Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
0 usd
CY2024Q1 karx Shares Issued As Stock Compensation
SharesIssuedAsStockCompensation
74998 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-21213 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-471271 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
772096 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
2265219 usd
karx Shares To Be Issued For Investment
SharesToBeIssuedForInvestment
375000 usd
karx Shares To Issued As Stock Compensation Amount
SharesToIssuedAsStockCompensationAmount
74998 usd
karx Issuance Of Shares For Cash And Warrants Net Amount
IssuanceOfSharesForCashAndWarrantsNetAmount
1655671 usd
karx Conversion Of Loan To Shares Amount
ConversionOfLoanToSharesAmount
100000 usd
karx Offering Expenses
OfferingExpenses
-3832 usd
karx Write Off Of Investment In Silviculture
WriteOffOfInvestmentInSilviculture
-1500000 usd
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-31594 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
680000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1803482 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
779604 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-32605 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1367 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
5320 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-375127 usd
us-gaap Net Income Loss
NetIncomeLoss
-2163366 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
772096 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
1636652 usd
CY2023Q1 karx Shares To Be Issued For Investment Amount
SharesToBeIssuedForInvestmentAmount
500000 usd
CY2023Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
33371 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-371789 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
1798234 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
637870 usd
karx Shares To Be Issued For Investment
SharesToBeIssuedForInvestment
1125000 usd
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1720 usd
us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
678280 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
1398 usd
us-gaap Net Income Loss
NetIncomeLoss
-646034 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
1798234 usd
us-gaap Profit Loss
ProfitLoss
-2163366 usd
us-gaap Profit Loss
ProfitLoss
-646034 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1099 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
824 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
12265 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
0 usd
us-gaap Gain Loss On Investments
GainLossOnInvestments
-1191890 usd
us-gaap Gain Loss On Investments
GainLossOnInvestments
13391 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
24782 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
0 usd
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-19042 usd
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
21131 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
64363 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
25904 usd
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
10535 usd
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
177 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
0 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
0 usd
karx Increase Decrease In Due From Silviculture New
IncreaseDecreaseInDueFromSilvicultureNew
0 usd
karx Increase Decrease In Due From Silviculture New
IncreaseDecreaseInDueFromSilvicultureNew
147133 usd
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
37486 usd
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
14860 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
142899 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
81471 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-9073 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
0 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
34708 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-2808 usd
us-gaap Increase Decrease In Security Deposits
IncreaseDecreaseInSecurityDeposits
0 usd
us-gaap Increase Decrease In Security Deposits
IncreaseDecreaseInSecurityDeposits
-8296 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1038148 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-872883 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
0 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3046 usd
us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
727409 usd
us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
0 usd
us-gaap Payments For Capital Improvements
PaymentsForCapitalImprovements
0 usd
us-gaap Payments For Capital Improvements
PaymentsForCapitalImprovements
280169 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-727409 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-283215 usd
us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
151644 usd
us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
99604 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1651838 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
206820 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
477339 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
212140 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
102212 usd
karx Shares To Be Issued For The Silviculture Investment
SharesToBeIssuedForTheSilvicultureInvestment
0 usd
karx Shares To Be Issued For The Silviculture Investment
SharesToBeIssuedForTheSilvicultureInvestment
1125000 usd
karx Write Off Of Investment In Silviculture
WriteOffOfInvestmentInSilviculture
-1500000 usd
karx Write Off Of Investment In Silviculture
WriteOffOfInvestmentInSilviculture
0 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
karx Issued And Outstanding Shares Of Common Stock Converted Exchange Ratio Description
IssuedAndOutstandingSharesOfCommonStockConvertedExchangeRatioDescription
20,000-for-1
CY2024Q1 karx Shares Authorized
SharesAuthorized
20000000 shares
CY2024Q1 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
134 usd
CY2024Q1 karx Related Party Transaction Amounts Due From To Related Party
RelatedPartyTransactionAmountsDueFromToRelatedParty
99902 usd
us-gaap Other Operating Income
OtherOperatingIncome
4356124 usd
us-gaap Use Of Estimates
UseOfEstimates
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Preparation of the financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect certain reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the period. Accordingly, actual results could differ from those estimates. </p>
CY2024Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
10341 usd
CY2023Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
10312 usd
CY2024Q1 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
6626 usd
CY2023Q2 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
6607 usd
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Certain amounts in the consolidated financial statements for the prior year have been reclassified to conform to the current year presentation. These reclassifications had no impact on net earnings, financial position, or cash flows. </p>
CY2024Q1 karx Prepaid Value Of Common Credit Purchase
PrepaidValueOfCommonCreditPurchase
59939 usd
CY2023Q2 karx Prepaid Value Of Common Credit Purchase
PrepaidValueOfCommonCreditPurchase
0 usd
CY2024Q1 karx Prepaid Current Value Of Furniture
PrepaidCurrentValueOfFurniture
0 usd
CY2023Q2 karx Prepaid Current Value Of Furniture
PrepaidCurrentValueOfFurniture
59767 usd
CY2024Q1 us-gaap Prepaid Advertising
PrepaidAdvertising
32559 usd
CY2023Q2 us-gaap Prepaid Advertising
PrepaidAdvertising
0 usd
CY2024Q1 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
1977 usd
CY2023Q2 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
0 usd
CY2024Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
94475 usd
CY2023Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
59767 usd
CY2024Q1 karx Carbon Credit Inventory Amount
CarbonCreditInventoryAmount
223649 usd
CY2023Q2 karx Carbon Credit Inventory Amount
CarbonCreditInventoryAmount
80750 usd
CY2024Q1 us-gaap Other Inventory
OtherInventory
223649 usd
CY2023Q2 us-gaap Other Inventory
OtherInventory
80750 usd
CY2024Q1 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
3715 usd
CY2023Q2 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
3705 usd
CY2024Q1 us-gaap Real Estate Accumulated Depreciation
RealEstateAccumulatedDepreciation
2838 usd
CY2023Q2 us-gaap Real Estate Accumulated Depreciation
RealEstateAccumulatedDepreciation
1196 usd
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7503 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
9116 usd
karx Office Chairs Purchase
OfficeChairsPurchase
6607 usd
karx Computers Purchase
ComputersPurchase
3705 usd
CY2024Q1 us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
550 usd
us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
1650 usd
us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
824 usd
CY2024Q1 karx Issued Additional Common Stock
IssuedAdditionalCommonStock
61111 shares
CY2024Q1 us-gaap Convertible Debt
ConvertibleDebt
150000 usd
CY2024Q1 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
0.90
CY2024Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
37500 usd
CY2024Q1 us-gaap Subordinated Borrowing Interest Rate
SubordinatedBorrowingInterestRate
0.18 pure
CY2024Q1 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
1000000 usd
CY2024Q1 karx Warrants Issued
WarrantsIssued
10400 shares
us-gaap Warrant Exercise Price Decrease
WarrantExercisePriceDecrease
0.50
karx Value Of Warrants
ValueOfWarrants
2236 usd
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4140000 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.75
karx Weighted Average Remaining Contractual Life In Years Beginning Balance
WeightedAverageRemainingContractualLifeInYearsBeginningBalance
P0Y3M29D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
10400 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.50
karx Weighted Average Remaining Contractual Life In Years Granted
WeightedAverageRemainingContractualLifeInYearsGranted
P1Y8M1D
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4150400 shares
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.75
karx Weighted Average Remaining Contractual Life In Years Ending Balance
WeightedAverageRemainingContractualLifeInYearsEndingBalance
P0Y4M2D
CY2023Q2 karx Share Exchange Agreement
ShareExchangeAgreement
0.80 pure
CY2023Q2 karx Share Exchange Agreement Value
ShareExchangeAgreementValue
7250000 usd
CY2024Q1 karx Capitalized Software Development Cost For Software Sold To Customers
CapitalizedSoftwareDevelopmentCostForSoftwareSoldToCustomers
524282 usd
CY2023Q2 karx Capitalized Software Development Cost For Software Sold To Customers
CapitalizedSoftwareDevelopmentCostForSoftwareSoldToCustomers
522771 usd
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
17665 usd
CY2024Q1 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
4785 usd
CY2024Q1 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
28712 usd
CY2024Q1 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
28712 usd
CY2024Q1 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
7179 usd
CY2024Q1 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
0 usd
CY2024Q1 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
69388 usd
CY2024Q1 karx Less Imputed Interest
LessImputedInterest
-8157 usd
CY2024Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
61231 usd
CY2024Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
23521 usd
CY2024Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
37710 usd

Files In Submission

Name View Source Status
0001477932-24-002277-index-headers.html Edgar Link pending
0001477932-24-002277-index.html Edgar Link pending
0001477932-24-002277.txt Edgar Link pending
0001477932-24-002277-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
karx-20240229.xsd Edgar Link pending
karx_10q.htm Edgar Link pending
karx_ex311.htm Edgar Link pending
karx_ex312.htm Edgar Link pending
karx_ex321.htm Edgar Link pending
karx_ex322.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
karx-20240229_cal.xml Edgar Link unprocessable
karx-20240229_def.xml Edgar Link unprocessable
karx-20240229_lab.xml Edgar Link unprocessable
karx-20240229_pre.xml Edgar Link unprocessable
karx_10q_htm.xml Edgar Link completed
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable